Последние добавленные видео:
what-is-lorlatinib
-
7 лет назад
1400 7 лет назад 1:46Is lorlatinib a better option for NSCLC?
-
6 лет назад
36977 6 лет назад 2:50How do ALK-inhibitors work in ALK-positive lung cancer?
-
9 месяцев назад
361 9 месяцев назад 2:58What is LORLATINIB (Lobrena)? What is LORLATINIB used for? Side Effects and Instruccions
-
4 года назад
2417 4 года назад 2:39ESMO 2020 Highlights on 1st line lorlatinib for ALK+ NSCLC: The CROWN Study
-
6 лет назад
2206 6 лет назад 2:04Dr. Shaw Discusses Lorlatinib in Lung Cancer
-
6 лет назад
1267 6 лет назад 1:15Efficacy Results for Lorlatinib in Patients With ALK-Positive NSCLC
-
7 месяцев назад
137 7 месяцев назад 4:01FDA D.I.S.C.O. Burst Edition: Lorbrena (lorlatinib) for patients with metastatic non-small cell l...
-
4 года назад
659 4 года назад 3:43Lorlatinib takes CROWN in head-to-head comparison with crizotinib | Benjamin Solomon
-
2 года назад
886 2 года назад 1:35Real-world toxicities associated with lorlatinib in ALK+ NSCLC
-
3 года назад
383 3 года назад 4:11CROWN: biomarkers for lorlatinib response in patients with ALK+ NSCLC
-
5 лет назад
122 5 лет назад 1:55Geoffrey Oxnard, MD, on the effectiveness of lorlatinib as a frontline agent in ALK+ NSCLC
-
2 года назад
1235 2 года назад 2:37CROWN: lorlatinib in treatment-naïve patients with ALK-positive advanced NSCLC
-
6 лет назад
886 6 лет назад 2:16Dr. Shaw Discusses Efficacy of Lorlatinib in ALK+ NSCLC
-
5 лет назад
522 5 лет назад 1:30Efficacy of lorlatinib in NSCLC post-second generation ALK TKI
-
3 года назад
3134 3 года назад 59:02What's after Lorlatinib?
-
3 года назад
1664 3 года назад 6:14Lorlatinib as First-Line Treatment for ALK-Positive Advanced Lung Cancer
-
2 месяца назад
15 2 месяца назад 5:57What is the role for lorlatinib and brigatinib in ALK-rearranged NSCLC?
-
6 лет назад
372 6 лет назад 1:17Dr. Bazhenova on the Potential Approval of Lorlatinib for Patients With ALK-Positive NSCLC
-
5 лет назад
Lorlatinib is Already Failing
The speaker shares an update on their cancer treatment. Lorlatinib, a medication previously effective, is no longer working above the neck. They are undergoing radiation to address brain metastases and are awaiting new treatment options. The speaker will provide further updates as needed.
2813 5 лет назад 1:41 -
1 год назад
525 1 год назад 2:00Lorlatinib safe and effective for ALK-driven relapsed high-risk neuroblastoma